Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: The aim of this study is to evaluate the effectiveness and safety of JAK inhibitors in patients with moderate to severe atopic dermatitis by performing a systematic review and meta-analysis using data from studies in real-world settings.

Design: Systematic review and meta-analysis. Pooled estimates for effectiveness and safety were assessed using the Freeman-Tukey Double ArcSine method. Statistical heterogeneity was assessed using I statistics. A random-effects model (DerSimonian-Laird method) was applied to consider the heterogeneity within and between studies and to give a more conservative estimate. The study quality assessment tools developed by the National Heart, Lung, and Blood Institute were used.

Data Source: Relevant studies were searched in March 2025 using four databases: PubMed, Embase, Scopus, and Web of Science.

Eligibility Criteria: Studies evaluating the effectiveness or safety of systemic JAK inhibitors among patients with moderate to severe atopic dermatitis in a real-world setting were included.

Results: A total of 50 studies were included in this review. Regarding their effectiveness, the pooled estimates with a 95% CI of Eczema Area and Severity Index (EASI)-75 were 44% (34%-55%), 45% (28%-62%), 59% (51%-66%), 73% (64%-81%), 70% (57%-81%), and 86% (72%-96%) at 4, 8, 12, 16, 24, and 52 weeks. For safety, the most common adverse events were acne (16%), followed by increased creatine phosphokinase levels (13%) and increased lipids (12%).

Conclusion: Our meta-analysis of JAK inhibitors in patients with atopic dermatitis demonstrated that the overall outcomes from real-world settings are comparable to those from clinical trials.

Systematic Review Registration: Protocol Registration: PROSPERO CRD42024569258.

Download full-text PDF

Source
http://dx.doi.org/10.1111/cea.70125DOI Listing

Publication Analysis

Top Keywords

effectiveness safety
16
jak inhibitors
16
atopic dermatitis
16
systematic review
12
review meta-analysis
12
inhibitors patients
12
safety jak
8
patients moderate
8
moderate severe
8
severe atopic
8

Similar Publications

Ultra-High Zinc Utilization Enabled by MXene Anode for Flexible Dual-Plating Zn-Br Microbatteries.

J Phys Chem Lett

September 2025

College of Materials Science and Engineering, Sichuan University, No. 24 South Section 1, Yihuan Road, Chengdu 610065, P. R. China.

Aqueous zinc-ion microbatteries exhibit promising prospects for wearable devices due to their high safety and cost-effectiveness but face challenges such as low energy density and short cycle life. To address these challenges, a dual-plating flexible Zn-Br microbattery was developed using freestanding MXene films as a zinc metal free anode. The MXene anode retains no redundant Zn, as Zn from the electrolyte undergoes deposition/stripping reactions on its substrate, thereby eliminating the necessity for excess zinc.

View Article and Find Full Text PDF

The development of anode materials for lithium-ion batteries must meet the demands for high safety, high energy density, and fast-charging performance. TiNbO is notable for its high theoretical specific capacity, low structural strain, and exceptional fast-charging capability, attributed to its Wadsley-Roth crystal structure. However, its inherently poor conductivity has hindered its practical application.

View Article and Find Full Text PDF

Background: Electronic health records (EHRs) are a cornerstone of modern health care delivery, but their current configuration often fragments information across systems, impeding timely and effective clinical decision-making. In gynecological oncology, where care involves complex, multidisciplinary coordination, these limitations can significantly impact the quality and efficiency of patient management. Few studies have examined how EHR systems support clinical decision-making from the perspective of end users.

View Article and Find Full Text PDF

Efficacy and Safety of Hydrodissection-based Capsulectomy for Improving Cervical Mobility and Appearance After Expanded Flap Transfer.

J Craniofac Surg

September 2025

Scar and Wound Treatment Center, Plastic Surgery Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

An expander capsule is a fibrous membrane that forms around an expander after tissue expansion. However, whether the capsule should be removed after the expander is removed remains controversial. The authors aimed to investigate the efficacy and safety of cervical capsulectomy for improving neck mobility and appearance after expanded flap transfer.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-associated death globally. Second-line therapies are crucial for improving survival and quality of life among individuals suffering from advanced HCC who have not responded to first-line therapies. This study sought to evaluate the safety and efficacy of different second-line therapies for advanced HCC by network meta-analysis.

View Article and Find Full Text PDF